Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease.
D006916:5-Hydroxytryptophan / Q000378:metabolism; D000328:Adult; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000378:metabolism*; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine*; D007024:Hypotension, Orthostatic / Q000378:metabolism; D008297:Male; D008333:Mandelic Acids / Q000652:urine*; D008875:Middle Aged; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D010648:Phenylacetates / Q000652:urine*; D012701:Serotonin / Q000378:metabolism
D008333:Mandelic Acids; D010648:Phenylacetates; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan; D004296:Dopa Decarboxylase; D004298:Dopamine; D009638:Norepinephrine